Hoth Therapeutics Inc RKTO

US Pharmaceuticals

$0.80 ▲ +1.21% (+$0.01)

🗓️ Earnings Next Week

Open $0.80

Prev Close $0.79

Day Range $0.76 – $0.80

52W Range $0.70 – $2.45

Market Cap $17.87M

Beta 1.93

EPS (TTM) $-0.81

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2019-02-15
Shares Out.	21,020,000
Website	hoththerapeutics.com/ ↗
Phone	16467562997
Employees	3

About Hoth Therapeutics Inc

Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.

Hoth Therapeutics Inc is a publicly traded company under the ticker symbol RKTO on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.